Eversept Partners, LP Absci Corp Transaction History
Eversept Partners, LP
- $991 Million
- Q4 2024
A detailed history of Eversept Partners, LP transactions in Absci Corp stock. As of the latest transaction made, Eversept Partners, LP holds 199,464 shares of ABSI stock, worth $578,445. This represents 0.05% of its overall portfolio holdings.
Number of Shares
199,464
Previous 272,869
26.9%
Holding current value
$578,445
Previous $1.04 Million
49.9%
% of portfolio
0.05%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ABSI
# of Institutions
138Shares Held
58.9MCall Options Held
180KPut Options Held
139K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.27MShares$24 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$23.9 Million1.69% of portfolio
-
Fred Alger Management, LLC New York, NY6.51MShares$18.9 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$13.8 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $269M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....